Hypertension Market

Jun 01, 2026

Summary In May 2026, the FDA approved AstraZeneca's BAXFENDY (baxdrostat), the world's first aldosterone synthase inhibitor (ASI), marking the arrival of an entirely new pharmacological class for a condition that affects 1.4 billion people globally. The approval addresses a stubborn clinical gap. Despite exi...

Apr 08, 2024

After Johnson & Johnson reversed its decision last year regarding the acquisition of Tryvio (aprocitentan) in 2017, the original manufacturer of the hypertension treatment drug, Idorsia Pharmaceuticals has successfully guided the drug through the FDA approval process. The company stated that Tryvio, its endo...

May 17, 2019

World Hypertension Day The World Hypertension day is celebrated on May 17, 2019. The theme is Know Your Numbers with the aim to increase awareness of high blood pressure (BP) around the world and promote hypertension prevention, detection and control. Cardiovascular diseases occur due to high blood pre...